Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Tissue engineering scaffolds aim to mimic the extracellular matrix (ECM) for controlled growth factor release.
• Developing scaffolds with sustained bioactive growth factor delivery is crucial for effective tissue regeneration.

Purpose of the Study:

• To create and evaluate modified collagen scaffolds for controlled release of basic fibroblast growth factor (bFGF).
• To assess the impact of heparin immobilization on bFGF release and bioactivity in collagen matrices.

Main Methods:

• Collagen sponges were modified using EDC/NHS crosslinking and heparin immobilization.
• Scaffolds were seeded with human umbilical vein endothelial cells (HUVECs) and pre-adsorbed with bFGF.
• Sustained release and bioactivity of bFGF from modified scaffolds were evaluated.

Main Results:

• Modified collagen matrices supported HUVEC proliferation, migration, and uniform distribution.
• The EDC/NHS-H group showed superior sustained release and bioactive maintenance of bFGF compared to controls.
• Heparin immobilization significantly improved bFGF retention and controlled release properties.

Conclusions:

• Heparin-functionalized collagen scaffolds offer a promising platform for controlled bFGF delivery.
• These scaffolds have potential applications in tissue engineering due to enhanced endothelial cell support and growth factor management.